1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      New intermediate-stage subclassification for patients with hepatocellular carcinoma treated with transarterial chemoembolization.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The need for a subclassification of Barcelona Clinic Liver Cancer (BCLC) intermediate-stage (BCLC B) has arisen because of its diversity. We evaluated the prognostic capability of the BCLC B subclassification proposed by Bolondi et al. in patients treated with transarterial chemoembolization (TACE). Furthermore, we introduce a new subclassification for intermediate-stage hepatocellular carcinoma (HCC) by using a new parameter related to tumour burden (up-to-11 criteria).

          Related collections

          Author and article information

          Journal
          Liver Int.
          Liver international : official journal of the International Association for the Study of the Liver
          Wiley
          1478-3231
          1478-3223
          December 2017
          : 37
          : 12
          Affiliations
          [1 ] Department of Radiology and Research Institute of Radiology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Songpa-Gu, Seoul, Korea.
          [2 ] Department of Gastroenterology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Songpa-Gu, Seoul, Korea.
          Article
          10.1111/liv.13487
          28581250

          Comments

          Comment on this article